Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)
Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –
Elevance Health cash
Cash and short-term investments held at the end of each period.
Elevance Health's cash was $35.70B at Sep 30, 2026. For fiscal 2025 it was $35.38B, up 5.6% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $36.14B in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.38B | +5.6% |
| FY2024 | Dec 31, 2024 | $33.49B | -7.3% |
| FY2023 | Dec 31, 2023 | $36.14B | +8.4% |
| FY2022 | Dec 31, 2022 | $33.34B | +7.0% |
| FY2021 | Dec 31, 2021 | $31.15B | +6.8% |
| FY2020 | Dec 31, 2020 | $29.17B | +18.5% |
| FY2019 | Dec 31, 2019 | $24.61B | +19.3% |
| FY2018 | Dec 31, 2018 | $20.63B | -1.7% |
| FY2017 | Dec 31, 2017 | $20.99B | -1.2% |
| FY2016 | Dec 31, 2016 | $21.24B | +11.6% |
| FY2015 | Dec 31, 2015 | $19.03B | -3.0% |
| FY2014 | Dec 31, 2014 | $19.62B | +5.4% |
| FY2013 | Dec 31, 2013 | $18.62B | -4.0% |
| FY2012 | Dec 31, 2012 | $19.39B | +7.0% |
| FY2011 | Dec 31, 2011 | $18.11B | +1.4% |
| FY2010 | Dec 31, 2010 | $17.86B | -12.9% |
| FY2009 | Dec 31, 2009 | $20.51B | +447.2% |
| FY2008 | Dec 31, 2008 | $3.75B | +35.4% |
| FY2007 | Dec 31, 2007 | $2.77B | +6.4% |
| FY2006 | Dec 31, 2006 | $2.60B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $35.70B | +2.0% |
| Q2 FY2026 | Jun 30, 2026 | $35.95B | +6.2% |
| Q1 FY2026 | Mar 31, 2026 | $35.56B | +8.0% |
| Q4 FY2025 | Dec 31, 2025 | $35.38B | +5.6% |
| Q3 FY2025 | Sep 30, 2025 | $35.00B | -5.0% |
| Q2 FY2025 | Jun 30, 2025 | $33.86B | -4.3% |
| Q1 FY2025 | Mar 31, 2025 | $32.94B | -7.9% |
| Q4 FY2024 | Dec 31, 2024 | $33.49B | -7.3% |
| Q3 FY2024 | Sep 30, 2024 | $36.82B | -4.9% |
| Q2 FY2024 | Jun 30, 2024 | $35.40B | -6.9% |
| Q1 FY2024 | Mar 31, 2024 | $35.76B | -5.4% |
| Q4 FY2023 | Dec 31, 2023 | $36.14B | +8.4% |
| Q3 FY2023 | Sep 30, 2023 | $38.73B | +12.6% |
| Q2 FY2023 | Jun 30, 2023 | $38.01B | +18.0% |
| Q1 FY2023 | Mar 31, 2023 | $37.78B | +16.7% |
| Q4 FY2022 | Dec 31, 2022 | $33.34B | +7.0% |
| Q3 FY2022 | Sep 30, 2022 | $34.40B | +8.0% |
| Q2 FY2022 | Jun 30, 2022 | $32.22B | +3.6% |
| Q1 FY2022 | Mar 31, 2022 | $32.38B | -4.4% |
| Q4 FY2021 | Dec 31, 2021 | $31.15B | +6.8% |
| Q3 FY2021 | Sep 30, 2021 | $31.84B | +19.3% |
| Q2 FY2021 | Jun 30, 2021 | $31.11B | +10.9% |
| Q1 FY2021 | Mar 31, 2021 | $33.88B | +34.3% |
| Q4 FY2020 | Dec 31, 2020 | $29.17B | +18.5% |
| Q3 FY2020 | Sep 30, 2020 | $26.69B | +10.5% |
| Q2 FY2020 | Jun 30, 2020 | $28.05B | +20.9% |
| Q1 FY2020 | Mar 31, 2020 | $25.23B | +13.2% |
| Q4 FY2019 | Dec 31, 2019 | $24.61B | +19.3% |
| Q3 FY2019 | Sep 30, 2019 | $24.15B | +11.5% |
| Q2 FY2019 | Jun 30, 2019 | $23.20B | +6.6% |
| Q1 FY2019 | Mar 31, 2019 | $22.28B | +2.6% |
| Q4 FY2018 | Dec 31, 2018 | $20.63B | -1.7% |
| Q3 FY2018 | Sep 30, 2018 | $21.65B | -12.7% |
| Q2 FY2018 | Jun 30, 2018 | $21.76B | -7.4% |
| Q1 FY2018 | Mar 31, 2018 | $21.72B | -12.1% |
| Q4 FY2017 | Dec 31, 2017 | $20.99B | -1.2% |
| Q3 FY2017 | Sep 30, 2017 | $24.79B | – |
| Q2 FY2017 | Jun 30, 2017 | $23.51B | – |
| Q1 FY2017 | Mar 31, 2017 | $24.72B | – |
| Q4 FY2016 | Dec 31, 2016 | $21.24B | – |
See a number that looks wrong?